Health ❯ Healthcare

Therapeutics

Drug Development Cancer Treatment Targeted Therapy Regenerative Medicine Innovative Treatments Treatment Strategies Drug Discovery Immunotherapy Natural Therapies Pharmacology

CRISPR Therapeutics’ Pipeline Pitched as Path to One-Time Heart Risk Treatments

Backers see CTX310, CTX320 as single-dose edits that could replace lifelong lipid drugs.

Vitamin D Tied to Immune Shifts in IBD, Mayo-Led Study Finds

Antibodies Targeting a Bacteria-Only Sugar Clear Lethal Drug-Resistant Infections in Mice

Immune Atlas Sharpens Myeloma Risk Prediction as Dual-Target CAR T Counters BCMA Loss

China Approves Sanofi’s Qfitlia for Hemophilia A Prophylaxis and Cablivi for aTTP

UK and Singapore Unveil MHRA–HSA Innovation Corridor to Speed Patient Access to New Health Technologies

Enlivex Raises $212 Million to Build RAIN Token Treasury, Plans Matteo Renzi Board Appointment

Reprogrammed Human Stomach Organoids Produce Insulin, Temporarily Control Diabetes in Mice

Two Nature Studies Show FSP1 Blockade Triggers Ferroptosis and Shrinks Tumors in Mice

Eli Lilly Unveils $3 Billion Netherlands Plant for Oral GLP-1 Medicines as Stock Rises

Early Stem Cell Infusion After First Heart Attack Cuts Heart Failure Risk in Phase 3 Trial

Nagaland University Study Finds Oral Plant Compound Speeds Diabetic Wound Healing

Long-Read Sequencing and 'LongTrack' Map Donor Bacteria After Fecal Transplants

Nobel in Medicine Honors Brunkow, Ramsdell and Sakaguchi for Immune Tolerance Breakthrough

EU Regulators Back Uplizna as First Treatment for IgG4‑Related Disease

Small-Cell Lung Cancer Forms Functional Synapses With Neurons, Nature Study Finds

Preclinical Study Highlights HER2 and CD24 as Radiotheranostic Targets in Endometrial Cancer

RUNX2 and BHLHE40 Identified as Drivers of Pathogenic T Cells in Crohn’s Disease

Beta-Cell GLUT Trafficking Breakdown Tied to Reduced Insulin Secretion in Type 2 Diabetes

Mitochondrial Designer Receptor Validates Causal Role in Neurodegeneration and Restores Memory in Mice